A team from the University of the Michigan and the VA question the National Institutes of Health guidelines that call for aggressive cholesterol lowering in people at high risk of, or who have already suffered, heart attacks and strokes. In a review in the October 2006 Annals of Internal Medicine, three researchers write that the "current clinical evidence does not support" the idea that aggressive statin therapy to achieve very low cholesterol levels for high-risk people "is beneficial or safe."
Of course, the guidelines in question are the ones for which eight out of nine guideline authors had financial ties to manufacturers of statin drugs.
Posted by schwitz at October 27, 2006 07:51 AM | TrackBack